Aug 30, 2019

YouTube reportedly settles with FTC over children's privacy violation

Illustration: Rebecca Zisser/Axios

Google has agreed to pay a $150-$200 million fine to the Federal Trade Commission for violating children's online privacy laws via its video platform YouTube, Politico reports.

Our thought bubble: It's a small fine given how much backlash YouTube has experienced over the past year for not adequately policing content and advertising on its platform that is aimed at children.

Details: According to the report, the FTC voted 3-2 along party lines to approve the settlement. Reports have suggested that the FTC was looking into whether YouTube was collecting data from children under 13 years old to serve up targeted ads.

Yes, but: Critics argue the fine doesn't go far enough, especially given how much cash Google has and how influential YouTube has become in children's media diets.

"[I]f the FTC fines Google only $200 million, that’s terribly inadequate. They have allowed YouTube to build a children’s media empire through illegal means that now, no one can compete with; all for the cost of a fine which is the equivalent of two to three months of YouTube ad revenue."
— Josh Golin, executive director, Campaign for a Commercial-Free Childhood

Meanwhile, YouTube has taken precautions to ensure that its kids content and policies don't attract more scrutiny from policymakers and advertisers in the future.

  • Ahead of the settlement, YouTube said it's creating a separate website for YouTube kids, previously only accessible via a mobile app.
  • YouTube will also reportedly end targeted advertising on videos aimed at children, Bloomberg reports.

The big picture: The fine is the latest action the FTC has taken to rein in children's privacy violations over the past year. In February, the Chinese-owned video app TikTok agreed to a $5.7 million settlement with the U.S. FTC for violating the Children's Online Privacy Protection Act (COPPA).

What's next: The settlement will head to the Justice Department for review.

Go deeper:

Go deeper

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 2 p.m. ET: 5,453,784 — Total deaths: 345,886 — Total recoveries — 2,191,310Map.
  2. U.S.: Total confirmed cases as of 2 p.m. ET: 1,651,254 — Total deaths: 97,850 — Total recoveries: 366,736 — Total tested: 14,163,915Map.
  3. World: Top Boris Johnson aide defends himself after allegations he broke U.K. lockdown — WHO suspends trial of hydroxychloroquine over safety concerns.
  4. 2020: Trump threatens to move Republican convention from North Carolina — Joe Biden makes first public appearance in two months.
  5. Public health: Officials are urging Americans to wear masks over Memorial Day.
  6. Economy: White House economic adviser Kevin Hassett says it's possible the unemployment rate could still be in double digits by November's election — Charities refocus their efforts to fill gaps left by government.
  7. What should I do? Hydroxychloroquine questions answeredTraveling, asthma, dishes, disinfectants and being contagiousMasks, lending books and self-isolatingExercise, laundry, what counts as soap — Pets, moving and personal healthAnswers about the virus from Axios expertsWhat to know about social distancingHow to minimize your risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it, the right mask to wear.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Updated 7 mins ago - Politics & Policy

Joe Biden makes first public appearance in over two months

Photo: Oliver Douliery/AFP via Getty Images

Former Vice President Joe Biden made his first in-person appearance in over two months on Monday to honor Memorial Day by laying a wreath at a Delaware veterans park, AP reports.

Why it matters: Biden, the Democratic Party's presumptive nominee, has taken the unprecedented step of campaigning from his home during the coronavirus pandemic, ever since canceling a rally in Cleveland on March 10.

WHO temporarily suspends trial of hydroxychloroquine over safety concerns

Photo: Fabrice Coffrini/AFP via Getty Images

The World Health Organization is temporarily pausing tests of the anti-malarial drug hydroxychloroquine as a coronavirus treatment in order to review safety concerns, the agency's director-general Tedros Adhanom Ghebreyesu said Monday.

Why it matters: The decision comes after a retrospective review published in The Lancet found that coronavirus patients who took hydroxychloroquine or its related drug chloroquine were more likely to die or develop an irregular heart rhythm that can lead to sudden cardiac death, compared to those who did nothing.